Immunopharmacological modulation of mast cells

Current Opinion in Pharmacology

Volumn 17, Issue 1, 2014, Pages 45-57

  Borriello, Francesco ^a   Granata, Francescopaolo ^a   Varricchi, Gilda ^a   Genovese, Arturo ^a   Triggiani, Massimo ^b   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CD72 ANTIGEN; CROMOGLYCATE DISODIUM; FC EPSILON RECEPTOR 1; FC RECEPTOR; GLUCOCORTICOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN RECEPTOR; IMMUNOPHILIN; ION CHANNEL; LECTIN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PHOSPHODIESTERASE INHIBITOR; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR; CYCLIC AMP; CYCLOOXYGENASE 2; CYCLOSPORIN A; HISTAMINE H4 RECEPTOR; HYPOTHEMYCIN; MAMMALIAN TARGET OF RAPAMYCIN; NEDOCROMIL; PIMECROLIMUS; PROSTAGLANDIN D2; PROTEIN KINASE SYK INHIBITOR; STEM CELL FACTOR; TACROLIMUS;

CELL ACTIVATION; CELL STIMULATION; DRUG MECHANISM; DRUG TARGETING; HUMAN; IMMUNOMODULATION; MAST CELL; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DEGRANULATION; DRUG DESIGN; DRUG EFFECTS; IMMUNOLOGY; MASTOCYTOSIS; MOLECULARLY TARGETED THERAPY; ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BASOPHIL; BRONCHOSPASM; CHRONIC IDIOPATHIC URTICARIA; CHRONIC URTICARIA; CYTOKINE PRODUCTION; HISTAMINE RELEASE; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; MAST CELL ACTIVATION; MAST CELL DEGRANULATION; PASSIVE SKIN ANAPHYLAXIS; PROSTAGLANDIN RELEASE; RHEUMATOID ARTHRITIS; URTICARIA PIGMENTOSA;

ANIMALS; CELL DEGRANULATION; DRUG DESIGN; HUMANS; IMMUNOLOGIC FACTORS; MAST CELLS; MASTOCYTOSIS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION;

EID: 84904962384     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.07.002     Document Type: Review

References (196)

1. G. Marone, L.M. Lichtenstein, and S. Galli Mast Cells and Basophils 2000 Academic Press
2. S.J. Galli, J. Kalesnikoff, M.A. Grimbaldeston, A.M. Piliponsky, C.M. Williams, and M. Tsai Mast cells as 'tunable' effector and immunoregulatory (Pubitemid 40563184)
3. A.S. Kirshenbaum, S.W. Kessler, J.P. Goff, and D.D. Metcalfe Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells J Immunol 146 1991 1410 1415
4. M. Rottem, T. Okada, J.P. Goff, and D.D. Metcalfe Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population Blood 84 1994 2489 2496
5. P. Valent, E. Spanblochl, W.R. Sperr, C. Sillaber, K.M. Zsebo, H. Agis, H. Strobl, K. Geissler, P. Bettelheim, and K. Lechner Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture Blood 80 1992 2237 2245
6. S.J. Galli, and M. Tsai IgE and mast cells in allergic disease Nat Med 18 2012 693 704
7. D.D. Metcalfe Mast cells and mastocytosis Blood 112 2008 946 956
8. L.L. Reber, T. Marichal, and S.J. Galli New models for analyzing mast cell functions in vivo Trends Immunol 33 2012 613 625
9. A. Dudeck, J. Dudeck, J. Scholten, A. Petzold, S. Surianarayanan, A. Kohler, K. Peschke, D. Vohringer, C. Waskow, and T. Krieg et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens Immunity 34 2011 973 984
10. T.B. Feyerabend, A. Weiser, A. Tietz, M. Stassen, N. Harris, M. Kopf, P. Radermacher, P. Moller, C. Benoist, and D. Mathis et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity Immunity 35 2011 832 844
11. J.N. Lilla, C.C. Chen, K. Mukai, M.J. BenBarak, C.B. Franco, J. Kalesnikoff, M. Yu, M. Tsai, A.M. Piliponsky, and S.J. Galli Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice Blood 118 2011 6930 6938
12. A. Detoraki, R.I. Staiano, F. Granata, G. Giannattasio, N. Prevete, A. de Paulis, D. Ribatti, A. Genovese, M. Triggiani, and G. Marone Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects J Allergy Clin Immunol 123 2009 1142 1149 e1141-1145
13. R.M. Melillo, V. Guarino, E. Avilla, M.R. Galdiero, F. Liotti, N. Prevete, F.W. Rossi, F. Basolo, C. Ugolini, and A. de Paulis et al. Mast cells have a protumorigenic role in human thyroid cancer Oncogene 29 2010 6203 6215
14. A. Rabenhorst, M. Schlaak, L.C. Heukamp, A. Forster, S. Theurich, M. von Bergwelt-Baildon, R. Buttner, P. Kurschat, C. Mauch, and A. Roers et al. Mast cells play a protumorigenic role in primary cutaneous lymphoma Blood 120 2012 2042 2054
15. E. Jensen-Jarolim, G. Achatz, M.C. Turner, S. Karagiannis, F. Legrand, M. Capron, M.L. Penichet, J.A. Rodríguez, A.G. Siccardi, and L. Vangelista et al. AllergoOncology: the role of IgE-mediated allergy in cancer Allergy 63 2008 1255 1266
16. M. Akahoshi, C.H. Song, A.M. Piliponsky, M. Metz, A. Guzzetta, M. Abrink, S.M. Schlenner, T.B. Feyerabend, H.R. Rodewald, and G. Pejler et al. Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice J Clin Invest 121 2011 4180 4191
17. T. Marichal, P. Starkl, L.L. Reber, J. Kalesnikoff, H.C. Oettgen, M. Tsai, M. Metz, and S.J. Galli A beneficial role for immunoglobulin E in host defense against honeybee venom Immunity 39 2013 963 975
18. M. Metz, A.M. Piliponsky, C.C. Chen, V. Lammel, M. Abrink, G. Pejler, M. Tsai, and S.J. Galli Mast cells can enhance resistance to snake and honeybee venoms Science 313 2006 526 530 (Pubitemid 44148458)
19. N.W. Palm, R.K. Rosenstein, S. Yu, D.D. Schenten, E. Florsheim, and R. Medzhitov Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity Immunity 39 2013 976 985
20. L.A. Schneider, S.M. Schlenner, T.B. Feyerabend, M. Wunderlin, and H.R. Rodewald Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin J Exp Med 204 2007 2629 2639 (Pubitemid 350044788)
21. C.Y. Chan, A.L. St John, and S.N. Abraham Plasticity in mast cell responses during bacterial infections Curr Opin Microbiol 15 2012 78 84
22. A. de Paulis, A. Ciccarelli, I. Marino, G. de Crescenzo, D. Marino, and G. Marone Human synovial mast cells II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs Arthritis Rheum 40 1997 469 478
23. M.F. Gurish, and K.F. Austen Developmental origin and functional specialization of mast cell subsets Immunity 37 2012 25 33
24. I. Halova, L. Draberova, and P. Draber Mast cell chemotaxis - chemoattractants and signaling pathways Front Immunol 3 2012 119
25. I.T. Harvima, F. Levi-Schaffer, P. Draber, S. Friedman, I. Polakovicova, B.F. Gibbs, U. Blank, G. Nilsson, and M. Maurer Molecular targets on mast cells and basophils for novel therapies J Allergy Clin Immunol 2014 10.1016/j.jaci.2014.03.0077
26. P.J. Barnes Drugs for asthma Br J Pharmacol 147 Suppl. 1 2006 S297 S303
27. P.J. Barnes Effect of beta-agonists on inflammatory cells J Allergy Clin Immunol 104 1999 S10 S17
28. Y. Okayama, and M.K. Church Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells Int Arch Allergy Immunol 97 1992 216 225
29. M. Shichijo, N. Inagaki, N. Nakai, M. Kimata, T. Nakahata, I. Serizawa, Y. Iikura, H. Saito, and H. Nagai The effects of anti-asthma drugs on mediator release from cultured human mast cells Clin Exp Allergy 28 1998 1228 1236 (Pubitemid 29087013)
30. X.S. Wang, and H.Y. Lau Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells Clin Exp Pharmacol Physiol 33 2006 746 750 (Pubitemid 44060768)
31. A.M. Scola, M. Loxham, S.J. Charlton, and P.T. Peachell The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells Br J Pharmacol 158 2009 267 276
32. N.W. Lukacs, S.L. Kunkel, R.M. Strieter, H.L. Evanoff, R.G. Kunkel, M.L. Key, and D.D. Taub The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation Blood 87 1996 2262 2268 (Pubitemid 26086865)
33. T. Takaishi, Y. Morita, K. Hirai, M. Yamaguchi, K. Ohta, E. Noda, T. Morita, K. Ito, and T. Miyamoto Effect of cytokines on mediator release from human dispersed lung mast cells Allergy 49 1994 837 842
34. G. Cruse, W. Yang, S.M. Duffy, L. Chachi, M. Leyland, Y. Amrani, and P. Bradding Counterregulation of beta(2)-adrenoceptor function in human mast cells by stem cell factor J Allergy Clin Immunol 125 2010 e251 e255 257-263
35. A. de Paulis, G. Minopoli, E. Arbustini, G. de Crescenzo, F. Dal Piaz, P. Pucci, T. Russo, and G. Marone Stem cell factor is localized in, released from, and cleaved by human mast cells J Immunol 163 1999 2799 2808 (Pubitemid 29399208)
36. S.Z. Al-Muhsen, G. Shablovsky, R. Olivenstein, B. Mazer, and Q. Hamid The expression of stem cell factor and c-kit receptor in human asthmatic airways Clin Exp Allergy 34 2004 911 916 (Pubitemid 38824069)
37. C.A. Da Silva, F. Blay, D. Israel-Biet, A.M. Laval, N. Glasser, G. Pauli, and N. Frossard Effect of glucocorticoids on stem cell factor expression in human asthmatic bronchi Clin Exp Allergy 36 2006 317 324 (Pubitemid 43344713)
38. C.P. Page, and D. Spina Selective PDE inhibitors as novel treatments for respiratory diseases Curr Opin Pharmacol 12 2012 275 286
39. N. Eskandari, R. Bastan, and P.T. Peachell Regulation of human skin mast cell histamine release by PDE inhibitors Allergol Immunopathol (Madr) 2013 10.1016/j.aller.2013.07.011
40. M.C. Weston, N. Anderson, and P.T. Peachell Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function Br J Pharmacol 121 1997 287 295 (Pubitemid 27192716)
41. J.C. Foreman, and L.G. Garland Cromoglycate and other antiallergic drugs: a possible mechanism of action Br Med J 1 1976 820 821
42. 2+ influx and degranulation capacity of variant RBL-2H3 cells upon implantation of isolated cromolyn binding protein Proc Natl Acad Sci U S A 80 1983 6014 6018 (Pubitemid 14228234)
43. S. Yazid, A. Sinniah, E. Solito, V. Calder, and R.J. Flower Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1 PLOS ONE 8 2013 e58963
44. S. Yazid, G. Leoni, S.J. Getting, D. Cooper, E. Solito, M. Perretti, and R.J. Flower Antiallergic cromones inhibit neutrophil recruitment onto vascular endothelium via annexin-A1 mobilization Arterioscler Thromb Vasc Biol 30 2010 1718 1724
45. S. Yazid, E. Solito, H. Christian, S. McArthur, N. Goulding, and R. Flower Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1 Biochem Pharmacol 77 2009 1814 1826
46. T. Oka, J. Kalesnikoff, P. Starkl, M. Tsai, and S.J. Galli Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice Lab Invest 92 2012 1472 1482
47. W.A. Velema, M. van der Toorn, W. Szymanski, and B.L. Feringa Design, synthesis, and inhibitory activity of potent, photoswitchable mast cell activation inhibitors J Med Chem 56 2013 4456 4464
48. C. Stellato Glucocorticoid actions on airway epithelial responses in immunity: functional outcomes and molecular targets J Allergy Clin Immunol 120 2007 1245 1264 1247-1263; quiz
49. E. Oppong, N. Flink, and A.C. Cato Molecular mechanisms of glucocorticoid action in mast cells Mol Cell Endocrinol 380 2013 119 126
50. M. Benhamou, E. Ninio, P. Salem, C. Hieblot, G. Bessou, C. Pitton, F.T. Liu, and J.M. Mencia-Huerta Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone J Immunol 136 1986 1385 1392 (Pubitemid 16156245)
51. J.L. Robin, D.C. Seldin, K.F. Austen, and R.A. Lewis Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids J Immunol 135 1985 2719 2726 (Pubitemid 16217142)
52. M. Yamaguchi, K. Hirai, A. Komiya, M. Miyamasu, Y. Furumoto, R. Teshima, K. Ohta, Y. Morita, S.J. Galli, and C. Ra et al. Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone Int Immunol 13 2001 843 851 (Pubitemid 32685197)
53. J. Zhou, D.F. Liu, C. Liu, Z.M. Kang, X.H. Shen, Y.Z. Chen, T. Xu, and C.L. Jiang Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism Allergy 63 2008 1177 1185
54. P. Goldsmith, B. McGarity, A.F. Walls, M.K. Church, G.H. Millward-Sadler, and D.A. Robertson Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease Dig Dis Sci 35 1990 1409 1413 (Pubitemid 20377973)
55. R.M. Lavker, and N.M. Schechter Cutaneous mast cell depletion results from topical corticosteroid usage J Immunol 135 1985 2368 2373 (Pubitemid 16217122)
56. S. Finotto, Y.A. Mekori, and D.D. Metcalfe Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems J Clin Invest 99 1997 1721 1728 (Pubitemid 27163824)
57. O. Kassel, F. Schmidlin, C. Duvernelle, F. de Blay, and N. Frossard Up- and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture Mol Pharmacol 54 1998 1073 1079 (Pubitemid 29002051)
58. B.K. Wershil, G.T. Furuta, J.A. Lavigne, A.R. Choudhury, Z.S. Wang, and S.J. Galli Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse J Immunol 154 1995 1391 1398
59. A. Kato, R.T. Chustz, T. Ogasawara, M. Kulka, H. Saito, R.P. Schleimer, and K. Matsumoto Dexamethasone FK506 inhibit expression of distinct subsets of chemokines in human mast cells J Immunol 182 2009 7233 7243
60. K. Matsuda, A.M. Piliponsky, M. Iikura, S. Nakae, E.W. Wang, S.M. Dutta, T. Kawakami, M. Tsai, and S.J. Galli Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response J Allergy Clin Immunol 116 2005 1357 1363 (Pubitemid 41740949)
61. V. Casolaro, S. Meliota, O. Marino, V. Patella, A. de Paulis, G. Guidi, and G. Marone Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells J Pharmacol Exp Ther 267 1993 1375 1385 (Pubitemid 24068710)
62. V. Patella, G. de Crescenzo, I. Marino, A. Genovese, M. Adt, G.J. Gleich, and G. Marone Eosinophil granule proteins activate human heart mast cells J Immunol 157 1996 1219 1225
63. A. Ward, and R.N. Brogden Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states Drugs 36 1988 732 753 (Pubitemid 19002886)
64. L. Andri, G. Senna, C. Betteli, S. Givanni, I. Scaricabarozzi, P. Mezzelani, and G. Andri Tolerability of nimesulide in aspirin-sensitive patients Ann Allergy 72 1994 29 32 (Pubitemid 24041080)
65. A. Bennett, and G. Villa Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities Expert Opin Pharmacother 1 2000 277 286
66. S. Spiegel, and S. Milstien The outs and the ins of sphingosine-1- phosphate in immunity Nat Rev Immunol 11 2011 403 415
67. C.A. Oskeritzian, S.E. Alvarez, N.C. Hait, M.M. Price, S. Milstien, and S. Spiegel Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions Blood 111 2008 4193 4200
68. O.H. Choi, J.H. Kim, and J.P. Kinet Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor Nature 380 1996 634 636 (Pubitemid 26119017)
69. P.S. Jolly, M. Bektas, A. Olivera, C. Gonzalez-Espinosa, R.L. Proia, J. Rivera, S. Milstien, and S. Spiegel Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis J Exp Med 199 2004 959 970 (Pubitemid 38481087)
70. 2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells J Biol Chem 277 2002 17255 17262 (Pubitemid 34967760)
71. A. Olivera, K. Mizugishi, A. Tikhonova, L. Ciaccia, S. Odom, R.L. Proia, and J. Rivera The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis Immunity 26 2007 287 297 (Pubitemid 46413904)
72. A. Olivera, N. Urtz, K. Mizugishi, Y. Yamashita, A.M. Gilfillan, Y. Furumoto, H. Gu, R.L. Proia, T. Baumruker, and J. Rivera IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses J Biol Chem 281 2006 2515 2525 (Pubitemid 43845711)
73. P.N. Pushparaj, J. Manikandan, H.K. Tay, S.C. H'Ng, S.D. Kumar, J. Pfeilschifter, A. Huwiler, and A.J. Melendez Sphingosine kinase 1 is pivotal for Fc epsilon RI-mediated mast cell signaling and functional responses in vitro and in vivo J Immunol 183 2009 221 227
74. M.M. Price, C.A. Oskeritzian, Y.T. Falanga, K.B. Harikumar, J.C. Allegood, S.E. Alvarez, D. Conrad, J.J. Ryan, S. Milstien, and S. Spiegel A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma J Allergy Clin Immunol 131 2013 501 511.e501
75. S. Nakae, C. Lunderius, L.H. Ho, B. Schafer, M. Tsai, and S.J. Galli TNF can contribute to multiple features of ovalbumin-induced allergic inflammation of the airways in mice J Allergy Clin Immunol 119 2007 680 686
76. C.M. Williams, and S.J. Galli Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice J Exp Med 192 2000 455 462 (Pubitemid 30629171)
77. A.M. Gilfillan, and J. Rivera The tyrosine kinase network regulating mast cell activation Immunol Rev 228 2009 149 169
78. E. Huang, K. Nocka, D.R. Beier, T.Y. Chu, J. Buck, H.W. Lahm, D. Wellner, P. Leder, and P. Besmer The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus Cell 63 1990 225 233
79. K.M. Zsebo, D.A. Williams, E.N. Geissler, V.C. Broudy, F.H. Martin, H.L. Atkins, R.Y. Hsu, N.C. Birkett, K.H. Okino, and D.C. Murdock et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor Cell 63 1990 213 224
80. K.M. Zsebo, J. Wypych, I.K. McNiece, H.S. Lu, K.A. Smith, S.B. Karkare, R.K. Sachdev, V.N. Yuschenkoff, N.C. Birkett, and L.R. Williams et al. Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver - conditioned medium Cell 63 1990 195 201
81. D.M. Anderson, S.D. Lyman, A. Baird, J.M. Wignall, J. Eisenman, C. Rauch, C.J. March, H.S. Boswell, S.D. Gimpel, and D. Cosman et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms Cell 63 1990 235 243
82. A.C. Garcia-Montero, M. Jara-Acevedo, C. Teodosio, M.L. Sanchez, R. Nunez, A. Prados, I. Aldanondo, L. Sanchez, M. Dominguez, and L.M. Botana et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients Blood 108 2006 2366 2372 (Pubitemid 44497521)
83. H. Nagata, A.S. Worobec, C.K. Oh, B.A. Chowdhury, S. Tannenbaum, Y. Suzuki, and D.D. Metcalfe Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder Proc Natl Acad Sci U S A 92 1995 10560 10564
84. Y. Ma, S. Zeng, D.D. Metcalfe, C. Akin, S. Dimitrijevic, J.H. Butterfield, G. McMahon, and B.J. Longley The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations Blood 99 2002 1741 1744 (Pubitemid 34533049)
85. C. Ustun, D.L. DeRemer, and C. Akin Tyrosine kinase inhibitors in the treatment of systemic mastocytosis Leuk Res 35 2011 1143 1152
86. Y. Bai, G. Bandara, E. Ching Chan, I. Maric, O. Simakova, S.N. Bandara, W.P. Lu, S.C. Wise, D.L. Flynn, and D.D. Metcalfe et al. Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation Leukemia 27 2013 278 285
87. K.V. Gleixner, B. Peter, K. Blatt, V. Suppan, A. Reiter, D. Radia, E. Hadzijusufovic, and P. Valent Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V Haematologica 98 2013 1450 1457
88. D.S. El-Agamy Anti-allergic effects of nilotinib on mast cell-mediated anaphylaxis like reactions Eur J Pharmacol 680 2012 115 121
89. K. Yamaki, and S. Yoshino Tyrosine kinase inhibitor sunitinib relieves systemic and oral antigen-induced anaphylaxes in mice Allergy 67 2012 114 122
90. B.M. Jensen, M.A. Beaven, S. Iwaki, D.D. Metcalfe, and A.M. Gilfillan Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation J Pharmacol Exp Ther 324 2008 128 138 (Pubitemid 350294172)
91. S. Havard, A.M. Scola, L.J. Kay, S.S. Ishmael, D.W. MacGlashan Jr., and P.T. Peachell Characterization of syk expression in human lung mast cells: relationship with function Clin Exp Allergy 41 2011 378 388
92. C.L. Kepley, L. Youssef, R.P. Andrews, B.S. Wilson, and J.M. Oliver Syk deficiency in nonreleaser basophils J Allergy Clin Immunol 104 1999 279 284 (Pubitemid 29420421)
93. S.E. Lavens-Phillips, and D.W. MacGlashan Jr. The tyrosine kinases p53/56lyn and p72syk are differentially expressed at the protein level but not at the messenger RNA level in nonreleasing human basophils Am J Respir Cell Mol Biol 23 2000 566 571
94. D.W. MacGlashan Jr. Relationship between spleen tyrosine kinase and phosphatidylinositol 5′ phosphatase expression and secretion from human basophils in the general population J Allergy Clin Immunol 119 2007 626 633
95. E.S. Masuda, and J. Schmitz Syk inhibitors as treatment for allergic rhinitis Pulm Pharmacol Ther 21 2008 461 467 (Pubitemid 351625925)
96. E.O. Meltzer, R.B. Berkowitz, and E.B. Grossbard An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment J Allergy Clin Immunol 115 2005 791 796 (Pubitemid 40460855)
97. S. Matsubara, T. Koya, K. Takeda, A. Joetham, N. Miyahara, P. Pine, E.S. Masuda, C.H. Swasey, and E.W. Gelfand Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation Am J Respir Cell Mol Biol 34 2006 426 433
98. S. Matsubara, G. Li, K. Takeda, J.E. Loader, P. Pine, E.S. Masuda, N. Miyahara, S. Miyahara, J.J. Lucas, and A. Dakhama et al. Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness Am J Respir Crit Care Med 173 2006 56 63 (Pubitemid 43069788)
99. P.C. Penton, X. Wang, H. Amatullah, J. Cooper, K. Godri, M.L. North, N. Khanna, J.A. Scott, and C.W. Chow Spleen tyrosine kinase inhibition attenuates airway hyperresponsiveness and pollution-induced enhanced airway response in a chronic mouse model of asthma J Allergy Clin Immunol 131 2013 510 511 512-520
100. G.R. Stenton, M.K. Kim, O. Nohara, C.F. Chen, N. Hirji, F.L. Wills, M. Gilchrist, P.H. Hwang, J.G. Park, and W. Finlay et al. Aerosolized Syk antisense suppresses Syk expression, mediator release from macrophages, and pulmonary inflammation J Immunol 164 2000 3790 3797 (Pubitemid 30169836)
101. G.R. Stenton, M. Ulanova, R.E. Dery, S. Merani, M.K. Kim, M. Gilchrist, L. Puttagunta, S. Musat-Marcu, D. James, and A.D. Schreiber et al. Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase J Immunol 169 2002 1028 1036 (Pubitemid 34753463)
102. M.E. Weinblatt, A. Kavanaugh, M.C. Genovese, T.K. Musser, E.B. Grossbard, and D.B. Magilavy An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis N Engl J Med 363 2010 1303 1312
103. J.W. Friedberg, J. Sharman, J. Sweetenham, P.B. Johnston, J.M. Vose, A. Lacasce, J. Schaefer-Cutillo, S. De Vos, R. Sinha, and J.P. Leonard et al. Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia Blood 115 2010 2578 2585
104. A. Mocsai, J. Ruland, and V.L. Tybulewicz The SYK tyrosine kinase: a crucial player in diverse biological functions Nat Rev Immunol 10 2010 387 402
105. C. Lau, P. Castellanos, D. Ranev, X. Wang, and C.W. Chow HRV signaling in airway epithelial cells is regulated by ITAM-mediated recruitment and activation of Syk Protein Pept Lett 18 2011 518 529
106. C. Lau, X. Wang, L. Song, M. North, S. Wiehler, D. Proud, and C.W. Chow Syk associates with clathrin and mediates phosphatidylinositol 3-kinase activation during human rhinovirus internalization J Immunol 180 2008 870 880
107. X. Wang, C. Lau, S. Wiehler, A. Pow, T. Mazzulli, C. Gutierrez, D. Proud, and C.W. Chow Syk is downstream of intercellular adhesion molecule-1 and mediates human rhinovirus activation of p38 MAPK in airway epithelial cells J Immunol 177 2006 6859 6870 (Pubitemid 44715051)
108. W.N. Hait, M.W. Harding, and R.E. Handschumacher Calmodulin, cyclophilin, and cyclosporin A Science 233 1986 987 989 (Pubitemid 16011914)
109. R.F. Standaert, A. Galat, G.L. Verdine, and S.L. Schreiber Molecular cloning and overexpression of the human FK506-binding protein FKBP Nature 346 1990 671 674
110. S.J. O'Keefe, J. Tamura, R.L. Kincaid, M.J. Tocci, and E.A. O'Neill FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin Nature 357 1992 692 694
111. J. Liu, J.D. Farmer Jr., W.S. Lane, J. Friedman, I. Weissman, and S.L. Schreiber Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes Cell 66 1991 807 815 (Pubitemid 121001714)
112. R. Cirillo, M. Triggiani, L. Siri, A. Ciccarelli, G.R. Pettit, M. Condorelli, and G. Marone Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin J Immunol 144 1990 3891 3897 (Pubitemid 20171202)
113. A. de Paulis, R. Cirillo, A. Ciccarelli, M. Condorelli, and G. Marone FK-506 a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells J Immunol 146 1991 2374 2381
114. A. de Paulis, R. Cirillo, A. Ciccarelli, G. de Crescenzo, A. Oriente, and G. Marone Characterization of the anti-inflammatory effect of FK-506 on human mast cells J Immunol 147 1991 4278 4285
115. A. de Paulis, C. Stellato, R. Cirillo, A. Ciccarelli, A. Oriente, and G. Marone Anti-inflammatory effect of FK-506 on human skin mast cells J Invest Dermatol 99 1992 723 728 (Pubitemid 23002033)
116. C. Stellato, A. de Paulis, A. Ciccarelli, R. Cirillo, V. Patella, V. Casolaro, and G. Marone Anti-inflammatory effect of cyclosporin A on human skin mast cells J Invest Dermatol 98 1992 800 804
117. H.C. Williams Clinical practice. Atopic dermatitis N Engl J Med 352 2005 2314 2324
118. G. Marone Tacrolimus ointment for atopic dermatitis N Engl J Med 339 1998 1788 1789 1788; author reply
119. T. Ando, K. Matsumoto, S. Namiranian, H. Yamashita, H. Glatthorn, M. Kimura, B.R. Dolan, J.J. Lee, S.J. Galli, and Y. Kawakami et al. Mast cells are required for full expression of allergen/SEB-induced skin inflammation J Investig Dermatol 133 2013 2695 2705
120. T. Ando, W. Xiao, P. Gao, S. Namiranian, K. Matsumoto, Y. Tomimori, H. Hong, H. Yamashita, M. Kimura, and Kashiwakura J-II et al. Critical role for mast cell Stat5 activity in skin inflammation Cell Rep 6 2014 366 376
121. Y. Nakamura, J. Oscherwitz, K.B. Cease, S.M. Chan, R. Munoz-Planillo, M. Hasegawa, A.E. Villaruz, G.Y. Cheung, M.J. McGavin, and J.B. Travers et al. Staphylococcus delta-toxin induces allergic skin disease by activating mast cells Nature 503 2013 397 401
122. K. Toshiaki, A. Tomoaki, K. Miho, S.W. Bridget, and K. Yuko Mast cells in atopic dermatitis Curr Opin Immunol 21 2009 666 678
123. Z. Ma, J.P. Tovar, K.Y. Kwong, and D. Paek Pimecrolimus induces apoptosis of mast cells in a murine model of cutaneous mastocytosis Int Arch Allergy Immunol 153 2010 413 418
124. K.G. Foster, and D.C. Fingar Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony J Biol Chem 285 2010 14071 14077
125. M.S. Kim, H.S. Kuehn, D.D. Metcalfe, and A.M. Gilfillan Activation and function of the mTORC1 pathway in mast cells J Immunol 180 2008 4586 4595
126. D. Smrz, M.S. Kim, S. Zhang, B.A. Mock, S. Smrzova, W. DuBois, O. Simakova, I. Maric, T.M. Wilson, and D.D. Metcalfe et al. mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells Blood 118 2011 6803 6813
127. F.E. Simons, and K.J. Simons Histamine and H1-antihistamines: celebrating a century of progress J Allergy Clin Immunol 128 2011 1139 1150.e1134
128. L.M. Lichtenstein, and E. Gillespie The effects of the H1 and H2 antihistamines on 'allergic' histamine release and its inhibition by histamine J Pharmacol Exp Ther 192 1975 441 450
129. G. Marone, F. Granata, G. Spadaro, A.M. Onorati, and M. Triggiani Antiinflammatory effects of oxatomide J Investig Allergol Clin Immunol 9 1999 207 214 (Pubitemid 29447475)
130. V. Patella, G. de Crescenzo, O. Marino, G. Spadaro, A. Genovese, and G. Marone Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells Int Arch Allergy Immunol 111 1996 23 29 (Pubitemid 26334633)
131. M. Alevizos, A. Karagkouni, M. Vasiadi, N. Sismanopoulos, M. Makris, D. Kalogeromitros, and T.C. Theoharides Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor Ann Allergy Asthma Immunol 111 2013 542 547
132. M. Vasiadi, D. Kalogeromitros, D. Kempuraj, A. Clemons, B. Zhang, C. Chliva, M. Makris, A. Wolfberg, M. House, and T.C. Theoharides Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli Int Arch Allergy Immunol 151 2010 38 45
133. A. Genovese, V. Patella, G. De Crescenzo, A. De Paulis, G. Spadaro, and G. Marone Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells Clin Exp Allergy 27 1997 559 567 (Pubitemid 27241655)
134. K. Weller, and M. Maurer Desloratadine inhibits human skin mast cell activation and histamine release J Invest Dermatol 129 2009 2723 2726
135. P.N. Nielsen, P.S. Skov, L.K. Poulsen, M. Schmelz, and L.J. Petersen Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study Clin Exp Allergy 31 2001 1378 1384 (Pubitemid 32823874)
136. Y. Okayama, R.C. Benyon, M.A. Lowman, and M.K. Church In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin Allergy 49 1994 246 253
137. M. Triggiani, G. Giannattasio, B. Balestrieri, F. Granata, M.H. Gelb, A. de Paulis, and G. Marone Differential modulation of mediator release from human basophils and mast cells by mizolastine Clin Exp Allergy 34 2004 241 249 (Pubitemid 38315261)
138. L. O'Mahony, M. Akdis, and C.A. Akdis Regulation of the immune response and inflammation by histamine and histamine receptors J Allergy Clin Immunol 128 2011 1153 1162
139. C.L. Hofstra, P.J. Desai, R.L. Thurmond, and W.P. Fung-Leung Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells J Pharmacol Exp Ther 305 2003 1212 1221 (Pubitemid 36618001)
140. A. Mirzahosseini, B. Dalmadi, and P. Csutora Histamine receptor H4 regulates mast cell degranulation and IgE induced FcepsilonRI upregulation in murine bone marrow-derived mast cells Cell Immunol 283 2013 38 44
141. D.W. MacGlashan Jr. IgE-dependent signaling as a therapeutic target for allergies Trends Pharmacol Sci 33 2012 502 509
142. D. Mochly-Rosen, K. Das, and K.V. Grimes Protein kinase C, an elusive therapeutic target? Nat Rev Drug Discov 11 2012 937 957
143. I.T. Abdel-Raheem, I. Hide, Y. Yanase, Y. Shigemoto-Mogami, N. Sakai, Y. Shirai, N. Saito, F.M. Hamada, N.A. El-Mahdy, and D. Elsisy Ael et al. Protein kinase C-alpha mediates TNF release process in RBL-2H3 mast cells Br J Pharmacol 145 2005 415 423 (Pubitemid 40966270)
144. E.Y. Chang, Z. Szallasi, P. Acs, V. Raizada, P.C. Wolfe, C. Fewtrell, P.M. Blumberg, and J. Rivera Functional effects of overexpression of protein kinase C-alpha, -beta, -delta -epsilon, and -eta in the mast cell line RBL-2H3 J Immunol 159 1997 2624 2632 (Pubitemid 127681280)
145. G. Li, J.J. Lucas, and E.W. Gelfand Protein kinase C alpha, betaI, and betaII isozymes regulate cytokine production in mast cells through MEKK2/ERK5-dependent and -independent pathways Cell Immunol 238 2005 10 18 (Pubitemid 43288028)
146. Y. Liu, C. Graham, V. Parravicini, M.J. Brown, J. Rivera, and S. Shaw Protein kinase C theta is expressed in mast cells and is functionally involved in Fcepsilon receptor I signaling J Leukoc Biol 69 2001 831 840 (Pubitemid 32466423)
147. H. Nechushtan, M. Leitges, C. Cohen, G. Kay, and E. Razin Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cbeta Blood 95 2000 1752 1757 (Pubitemid 30120839)
148. 2+ and purified isozymes in washed permeabilized cells J Biol Chem 268 1993 1749 1756 (Pubitemid 23033568)
149. R. Sagi-Eisenberg, H. Lieman, and I. Pecht Protein kinase C regulation of the receptor-coupled calcium signal in histamine-secreting rat basophilic leukaemia cells Nature 313 1985 59 60 (Pubitemid 15192306)
150. M. Leitges, K. Gimborn, W. Elis, J. Kalesnikoff, M.R. Hughes, G. Krystal, and M. Huber Protein kinase C-delta is a negative regulator of antigen-induced mast cell degranulation Mol Cell Biol 22 2002 3970 3980 (Pubitemid 34556568)
151. K. Ozawa, K. Yamada, M.G. Kazanietz, P.M. Blumberg, and M.A. Beaven Different isozymes of protein kinase C mediate feedback inhibition of phospholipase C and stimulatory signals for exocytosis in rat RBL-2H3 cells J Biol Chem 268 1993 2280 2283 (Pubitemid 23057836)
152. V. Patella, V. Casolaro, A. Ciccarelli, G.R. Pettit, M. Columbo, and G. Marone The antineoplastic bryostatins affect human basophils and mast cells differently Blood 85 1995 1272 1281
153. N. Prevete, R.I. Staiano, F. Granata, A. Detoraki, V. Necchi, V. Ricci, M. Triggiani, A. De Paulis, G. Marone, and A. Genovese Expression and function of angiopoietins and their tie receptors in human basophils and mast cells J Biol Regul Homeost Agents 27 2013 827 839
154. R.P. Schleimer, E. Gillespie, and L.M. Lichtenstein Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response J Immunol 126 1981 570 574 (Pubitemid 11136715)
155. W.A. Massey, V.L. Cohan, D.W. MacGlashan Jr., S.W. Gittlen, A. Kagey-Sobotka, L.M. Lichtenstein, and J.A. Warner Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition J Pharmacol Exp Ther 258 1991 824 829
156. A.X. Wu-Zhang, and A.C. Newton Protein kinase C pharmacology: refining the toolbox Biochem J 452 2013 195 209
157. I. Ashmole, and P. Bradding Ion channels regulating mast cell biology Clin Exp Allergy 43 2013 491 502
158. + channels are required for human lung mast cell migration Thorax 61 2006 880 885 (Pubitemid 44570309)
159. I. Ashmole, S.M. Duffy, M.L. Leyland, V.S. Morrison, M. Begg, and P. Bradding CRACM/Orai ion channel expression and function in human lung mast cells J Allergy Clin Immunol 129 2012 1628 1635.e1622
160. S. Feske Calcium signalling in lymphocyte activation and disease Nat Rev Immunol 7 2007 690 702 (Pubitemid 47327393)
161. M. Humbert, R. Beasley, J. Ayres, R. Slavin, J. Hebert, J. Bousquet, K.M. Beeh, S. Ramos, G.W. Canonica, and S. Hedgecock et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE Allergy 60 2005 309 316 (Pubitemid 40293346)
162. L.A. Beck, G.V. Marcotte, D. MacGlashan, A. Togias, and S. Saini Omalizumab-induced reductions in mast cell Fce psilon RI expression and function J Allergy Clin Immunol 114 2004 527 530 (Pubitemid 39194924)
163. D.W. MacGlashan Jr., B.S. Bochner, D.C. Adelman, P.M. Jardieu, A. Togias, J. McKenzie-White, S.A. Sterbinsky, R.G. Hamilton, and L.M. Lichtenstein Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody J Immunol 158 1997 1438 1445 (Pubitemid 127469971)
164. C. Prussin, D.T. Griffith, K.M. Boesel, H. Lin, B. Foster, and T.B. Casale Omalizumab treatment downregulates dendritic cell FcepsilonRI expression J Allergy Clin Immunol 112 2003 1147 1154 (Pubitemid 37550008)
165. A.P. Kaplan, K. Joseph, R.J. Maykut, G.P. Geba, and R.K. Zeldin Treatment of chronic autoimmune urticaria with omalizumab J Allergy Clin Immunol 122 2008 569 573
166. M. Maurer, K. Rosen, H.J. Hsieh, S. Saini, C. Grattan, A. Gimenez-Arnau, S. Agarwal, R. Doyle, J. Canvin, and A. Kaplan et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria N Engl J Med 368 2013 924 935
167. J. Corren, G. Shapiro, J. Reimann, Y. Deniz, D. Wong, D. Adelman, and A. Togias Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy J Allergy Clin Immunol 121 2008 506 511 (Pubitemid 351215181)
168. J.M. McDonnell, A.J. Beavil, G.A. Mackay, B.A. Jameson, R. Korngold, H.J. Gould, and B.J. Sutton Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor Nat Struct Biol 3 1996 419 426 (Pubitemid 26139440)
169. M. Rossi, M. Ruvo, D. Marasco, M. Colombo, G. Cassani, and A. Verdoliva Anti-allergic properties of a new all-D synthetic immunoglobulin-binding peptide Mol Immunol 45 2008 226 234 (Pubitemid 47336969)
170. A. Sandomenico, S.M. Monti, D. Marasco, N. Dathan, R. Palumbo, M. Saviano, and M. Ruvo IgE-binding properties and selectivity of peptide mimics of the FcvarepsilonRI binding site Mol Immunol 46 2009 3300 3309
171. T.W. Wiegand, P.B. Williams, S.C. Dreskin, M.H. Jouvin, J.P. Kinet, and D. Tasset High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I J Immunol 157 1996 221 230
172. M.J. Baumann, A. Eggel, P. Amstutz, B.M. Stadler, and M. Vogel DARPins against a functional IgE epitope Immunol Lett 133 2010 78 84
173. A. Eggel, M.J. Baumann, P. Amstutz, B.M. Stadler, and M. Vogel DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage J Mol Biol 393 2009 598 607
174. B. Kim, A. Eggel, S.S. Tarchevskaya, M. Vogel, H. Prinz, and T.S. Jardetzky Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor Nature 491 2012 613 617
175. M. Daeron, S. Jaeger, L. Du Pasquier, and E. Vivier Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future Immunol Rev 224 2008 11 43
176. L. Karra, and F. Levi-Schaffer Down-regulation of mast cell responses through ITIM containing inhibitory receptors Adv Exp Med Biol 716 2011 143 159
177. D. Zhu, C.L. Kepley, M. Zhang, K. Zhang, and A. Saxon A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation Nat Med 8 2002 518 521 (Pubitemid 34546756)
178. G.J. Clark, X. Ju, C. Tate, and D.N. Hart The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions Trends Immunol 30 2009 209 217
179. H. Kumagai, T. Oki, K. Tamitsu, S.Z. Feng, M. Ono, H. Nakajima, Y.C. Bao, Y. Kawakami, K. Nagayoshi, and N.G. Copeland et al. Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells Biochem Biophys Res Commun 307 2003 719 729 (Pubitemid 36944992)
180. I. Bachelet, A. Munitz, A. Moretta, L. Moretta, and F. Levi-Schaffer The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells J Immunol 175 2005 7989 7995 (Pubitemid 41798360)
181. I. Bachelet, A. Munitz, B. Berent-Maoz, D. Mankuta, and F. Levi-Schaffer Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a J Immunol 180 2008 6064 6069
182. I. Bachelet, A. Munitz, and F. Levi-Schaffer Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a J Allergy Clin Immunol 117 2006 1314 1320 (Pubitemid 43795759)
183. V.R. Simhadri, J.F. Andersen, E. Calvo, S.C. Choi, J.E. Coligan, and F. Borrego Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells Blood 119 2012 2799 2809
184. M. Takahashi, K. Izawa, J. Kashiwakura, Y. Yamanishi, Y. Enomoto, A. Kaitani, A. Maehara, M. Isobe, S. Ito, and T. Matsukawa et al. Human CD300C delivers an Fc receptor-gamma-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition J Biol Chem 288 2013 7662 7675
185. C. Nakahashi-Oda, S. Tahara-Hanaoka, M. Shoji, Y. Okoshi, T. Nakano-Yokomizo, N. Ohkohchi, T. Yasui, H. Kikutani, S. Honda, and K. Shibuya et al. Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor J Exp Med 209 2012 1493 1503
186. K. Izawa, M. Isobe, T. Matsukawa, S. Ito, A. Maehara, M. Takahashi, Y. Yamanishi, A. Kaitani, T. Oki, and K. Okumura et al. Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcepsilonRI-mediated mast cell activation J Allergy Clin Immunol 133 2014 270 273 e271-277
187. K. Izawa, Y. Yamanishi, A. Maehara, M. Takahashi, M. Isobe, S. Ito, A. Kaitani, T. Matsukawa, T. Matsuoka, and F. Nakahara et al. The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide Immunity 37 2012 827 839
188. T. Kiwamoto, N. Kawasaki, J.C. Paulson, and B.S. Bochner Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions Pharmacol Ther 135 2012 327 336
189. H. Yokoi, O.H. Choi, W. Hubbard, H.S. Lee, B.J. Canning, H.H. Lee, S.D. Ryu, S. von Gunten, C.A. Bickel, and S.A. Hudson et al. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement J Allergy Clin Immunol 121 2008 499 505.e491
190. T.R. Kataoka, A. Kumanogoh, G. Bandara, D.D. Metcalfe, and A.M. Gilfillan CD72 negatively regulates KIT-mediated responses in human mast cells J Immunol 184 2010 2468 2475
191. H.J. Wu, and S. Bondada CD72 a coreceptor with both positive and negative effects on B lymphocyte development and function J Clin Immunol 29 2009 12 21
192. K. Hitomi, S. Tahara-Hanaoka, S. Someya, A. Fujiki, H. Tada, T. Sugiyama, S. Shibayama, K. Shibuya, and A. Shibuya An immunoglobulin-like receptor Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions Nat Immunol 11 2010 601 607
193. K. Nagai, S. Tahara-Hanaoka, Y. Morishima, T. Tokunaga, Y. Imoto, E. Noguchi, K. Kanemaru, M. Imai, S. Shibayama, and N. Hizawa et al. Expression and function of Allergin-1 on human primary mast cells PLOS ONE 8 2013 e76160
194. Gt. Andreas, S. Alina, L. Undine, K. Loreen, A. Metin, and M.H. Beate LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells Cytometry 61 2004 62 68
195. J. Abramson, R. Xu, and I. Pecht An unusual inhibitory receptor - the mast cell function-associated antigen (MAFA) Mol Immunol 38 2002 1307 1313 (Pubitemid 35253769)
196. J. Abramson, A. Licht, and I. Pecht Selective inhibition of the Fc epsilon RI-induced de novo synthesis of mediators by an inhibitory receptor EMBO J 25 2006 323 334 (Pubitemid 43152853)